Pain Update 4/14/00

Drug War Chronicle, recent top items


recent blog posts "In the Trenches" activist feed


A Senate Judiciary Committee has indefinitely postponed a legislative markup of H.R. 2250, the "Pain Relief Promotion Act," scheduled for Thursday, April 6, according to the Last Acts Policy Newsletter (  The bill, sponsored by Reps. Hyde and Nickles, was a response to the passage of laws legalizing assisted suicide, authorizing DEA to target physicians who provide opioids (narcotics) for suicide while providing education on pain management to address the problem of undertreatment.

The medical community has been divided on the bill, which some organizations believe would worsen the DEA's impact on the provision of opioid medications for severe, chronic pain.  (See our coverage of this legislation when it was introduced last June, "Palliative or Repressive?  Conservative-Sponsored Legislation Impacts on Pain, Suicide and Drug Policy Debates,"

The text, summary and status information on H.R. 2250 and any other federal legislation is available at

Also according to Last Acts, a recent study published by the Journal of the American Medical Association (vol. 283, no. 13) has found that increasing opioid use in pain management does not necessarily lead to an increase in drug abuse.  Using data from the Drug Abuse Warning Network (DAWN), David Joranson and colleagues at the Univ. of Wisconsin-Madison Medical School's Pain and Policy Studies Group found "data indicate that there is some abuse of opioid analgesics" but that "compared with... other drugs, ... the abuse of opioid analgesics appears to be relatively low.  The study can be found online at

Visit the American Society for Action on Pain at

-- END --
Link to Drug War Facts
Please make a generous donation to support Drug War Chronicle in 2007!          

PERMISSION to reprint or redistribute any or all of the contents of Drug War Chronicle (formerly The Week Online with DRCNet is hereby granted. We ask that any use of these materials include proper credit and, where appropriate, a link to one or more of our web sites. If your publication customarily pays for publication, DRCNet requests checks payable to the organization. If your publication does not pay for materials, you are free to use the materials gratis. In all cases, we request notification for our records, including physical copies where material has appeared in print. Contact: the Drug Reform Coordination Network, P.O. Box 18402, Washington, DC 20036, (202) 293-8340 (voice), (202) 293-8344 (fax), e-mail [email protected]. Thank you.

Articles of a purely educational nature in Drug War Chronicle appear courtesy of the DRCNet Foundation, unless otherwise noted.

Issue #133, 4/14/00 Canadian Senate Calls for Study of Drug Policy | Report Says Customs Targeted Black Women for Drug Searches, Customs Says Recent Reforms Are Working | House Approves Compromise Forfeiture Reform Bill | Dorothy Gaines Clemency Petition | The Corner to Premiere on HBO this Sunday | Pain Update | Job Opportunities in Harm Reduction

This issue -- main page
This issue -- single-file printer version
Drug War Chronicle -- main page
Chronicle archives
Out from the Shadows HEA Drug Provision Drug War Chronicle Perry Fund DRCNet en EspaŮol Speakeasy Blogs About Us Home
Why Legalization? NJ Racial Profiling Archive Subscribe Donate DRCNet em PortuguÍs Latest News Drug Library Search
special friends links: SSDP - Flex Your Rights - IAL - Drug War Facts the Drug Reform Coordination Network (DRCNet)
1623 Connecticut Ave., NW, 3rd Floor, Washington DC 20009 Phone (202) 293-8340 Fax (202) 293-8344 [email protected]